Luliconazole

Luliconazole

Systematic (IUPAC) name
(2E)-[(4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene](1H-imidazol-1-yl)acetonitrile
Clinical data
Trade names	Luzu, Lulicon
Routes of administration	Topical
Legal status	℞ (Prescription only)
Pharmacokinetic data
Protein binding	>99%[1]
Identifiers
CAS Number	187164-19-8
ATC code	D01AC18 (WHO)
PubChem	CID 3003141
ChemSpider	2273807
Chemical data
Formula	C14H9Cl2N3S2
Molar mass	354.28 g/mol
SMILES C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl
InChI InChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1 Key:YTAOBBFIOAEMLL-REQDGWNSSA-N

Luliconazole (trade names Luzu, Lulicon) is an imidazole antifungal drug. As a 1% topical cream, It is indicated for the treatment of athlete's foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum^[2] and Epidermophyton floccosum.^[1]

References

1. "LUZU (luliconazole) Cream, 1%. Full Prescribing Information." (PDF). Valeant Pharmaceuticals North America LLC. Retrieved 1 October 2015.
2. "FDA approves luliconazole for tinea pedis". November 19, 2013. Retrieved 14 January 2014.

External links

• Luliconazole